Kazia Therapeutics Ltd ADR
Kazia Therapeutics Ltd ADR (NASDAQ: KZIA) is trading at $9.57, about ₹918 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, down 2.15% today. Indian residents can buy Kazia Therapeutics Ltd ADR from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$9.42
Today's high
$9.80
52 week low
$4.86
52 week high
$17.40
KZIA opened at $9.78, closed previously at $9.78, and has traded between $4.86 and $17.40 over the past 52 weeks.
About
Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in Israel. The company's lead development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, which is in Phase II/III clinical trial for the treatment of glioblastoma; in Phase II trial to treat isocitrate dehydrogenase-mutant glioma, primary central nervous system (CNS) lymphoma, diffuse intrinsic pontine glioma, and brain metastases; and in pre-clinical studies to treat triple-negative breast cancer, as well as for the treatment of atypical rhabdoid/teratoid tumors. It also develops EVT801, a small-molecule selective inhibitor of vascular endothelial growth factor receptor 3 that is in Phase I clinical trial to treat advanced solid tumors and ovarian cancer. The company has collaborations with the Australian and New Zealand Children’s Haematology/Oncology Group, Genentech Inc., Global Coalition for Adaptive Research, Vivesto AB, Simcere Pharmaceutical Group Ltd, Evotec SE, Sovargen Co., Ltd, and QIMR Berghofer Medical Research Institute. Kazia Therapeutics Limited was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.
Key statistics
Avg. volume
242.99K
Market cap
$15.50M
P/E Ratio
-1.32
Price-to-sales ratio
1119.39
Enterprise value
-A$47.23M
Free cash flow yield
-41.13%
Debt-to-equity ratio
0.00
Return on equity
-116.86%
ROIC
-36.21%
Beta
2.15
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
A$42.00K
Earnings per share
-A$18.90
Free cash flow
-A$13.28M
Net profit margin
-113004.58%
Gross margin
100.00%
EBITDA
-A$13.28M
Revenue growth
-98.18%
Similar securities
This is not an investment recommendation
How to buy Kazia Therapeutics Ltd ADR from India
Indian residents can buy Kazia Therapeutics Ltd ADR shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Kazia Therapeutics Ltd ADR and place an order
Find Kazia Therapeutics Ltd ADR by name or by its ticker, KZIA, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Kazia Therapeutics Ltd ADR trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Kazia Therapeutics Ltd ADR position in USD and INR. Kazia Therapeutics Ltd ADR pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Trading and taxes when buying Kazia Therapeutics Ltd ADR from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneKazia Therapeutics Ltd ADR does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Kazia Therapeutics Ltd ADR stock?
Yes. Kazia Therapeutics Ltd ADR (KZIA) has been listed on NASDAQ since 1999, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Kazia Therapeutics Ltd ADR share cost in rupees?
One Kazia Therapeutics Ltd ADR share is $9.57 — about ₹918 at a USD/INR rate of 95.92 on 25 Sep 2026. Both the Kazia Therapeutics Ltd ADR price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Kazia Therapeutics Ltd ADR from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Kazia Therapeutics Ltd ADR?
Yes. One Kazia Therapeutics Ltd ADR share is $9.57, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Kazia Therapeutics Ltd ADR.
How are gains on Kazia Therapeutics Ltd ADR shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Kazia Therapeutics Ltd ADR price. Paasa issues a capital-gains statement for your return.
Does Kazia Therapeutics Ltd ADR pay a dividend?
No. Kazia Therapeutics Ltd ADR does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Kazia Therapeutics Ltd ADR from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is Kazia Therapeutics Ltd ADR a United States company, and does that change how it is taxed?
Kazia Therapeutics Ltd ADR trades on NASDAQ in US dollars, but the company is domiciled in Australia. Kazia Therapeutics Ltd ADR trades as an American Depositary Receipt rather than an ordinary share. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.
Do I have to declare Kazia Therapeutics Ltd ADR shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Kazia Therapeutics Ltd ADR holding, its cost and its closing value.
How do I sell Kazia Therapeutics Ltd ADR and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.